Stock Price
12.77
Daily Change
0.05 0.39%
Monthly
7.58%
Yearly
-1.47%
Q2 Forecast
12.04

Orthofix International reported $137.23M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 76.73M 521K Sep/2025
Dexcom USD 1.24B 1.21B Dec/2025
EDAP TMS EUR 7.55M 1.41M Sep/2025
Globus Medical USD 119.34M 1.76M Sep/2025
Inogen USD 0 0 Jun/2022
Insulet USD 1.01B 384.9M Sep/2025
Integra LifeSciences USD 2.01B 7.91M Sep/2025
J&J USD 47.93B 2.14B Dec/2025
Medtronic USD 28.07B 1.03B Dec/2025
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Orthofix International USD 137.23M 338K Sep/2024
Plus Therapeutics USD 3.98M 372K Dec/2023
Smith & Nephew USD 3.32B 334M Dec/2024
STAAR Surgical USD 39.12M 1.4M Sep/2025
Stryker USD 14.86B 1.74B Dec/2025
Surmodics USD 29.55M 111K Sep/2024
Tandem Diabetes Care USD 449.28M 276K Sep/2025
Teleflex USD 2.77B 774M Sep/2025
Veracyte USD 40.45M 10.19M Sep/2025
Zimmer Biomet Holdings USD 7.52B 593.5M Dec/2025